176 related articles for article (PubMed ID: 6666502)
1. Glycosylated hemoglobin in endogenous hypertriglyceridemia.
Fedele D; Lapolla A; Cardone C; Baldo G; Crepaldi G
Acta Diabetol Lat; 1983; 20(4):303-9. PubMed ID: 6666502
[TBL] [Abstract][Full Text] [Related]
2. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
Marini MA; Fiorentino TV; Andreozzi F; Mannino GC; Perticone M; Sciacqua A; Perticone F; Sesti G
Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
[TBL] [Abstract][Full Text] [Related]
3. Glycated serum proteins and glucose tolerance.
Lapolla A; Poli T; Meneghini F; Zucchetto M; Franchin A; Barison A; Fedele D
Acta Diabetol Lat; 1988; 25(4):325-32. PubMed ID: 3245392
[TBL] [Abstract][Full Text] [Related]
4. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
[TBL] [Abstract][Full Text] [Related]
5. The value of glycosylated haemoglobin as a substitute for the oral glucose tolerance test in the detection of impaired glucose tolerance (IGT).
Motala AA; Omar MA
Diabetes Res Clin Pract; 1992 Sep; 17(3):199-207. PubMed ID: 1425159
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
[TBL] [Abstract][Full Text] [Related]
7. Impaired glucose tolerance is not associated with lipid intolerance.
Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect?
Bourn DM; Mann JI; McSkimming BJ; Waldron MA; Wishart JD
Diabetes Care; 1994 Nov; 17(11):1311-9. PubMed ID: 7821173
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of glycated hemoglobin in the early diagnosis of diabetes mellitus].
Qiu WS
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):407-9, 443-4. PubMed ID: 2591259
[TBL] [Abstract][Full Text] [Related]
10. High risk of progression to NIDDM in South-African Indians with impaired glucose tolerance.
Motala AA; Omar MA; Gouws E
Diabetes; 1993 Apr; 42(4):556-63. PubMed ID: 8454106
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical reliability of fasting plasma glucose and glycosylated hemoglobin in non-insulin-dependent diabetes mellitus.
Pecoraro RE; Koepsell TD; Chen MS; Lipsky BA; Belcher DW; Inui TS
Diabetes Care; 1986; 9(4):370-5. PubMed ID: 3743312
[TBL] [Abstract][Full Text] [Related]
12. [Glycosylated hemoglobin in the diagnosis of diabetes mellitus].
Tian H; Lian J; Zhang X
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Jun; 21(2):197-200. PubMed ID: 2391104
[TBL] [Abstract][Full Text] [Related]
13. Brazilian individuals with impaired glucose tolerance are characterized by impaired insulin secretion.
Pimenta WP; Santos ML; Cruz NS; Aragon FF; Padovani CR; Gerich JE
Diabetes Metab; 2002 Dec; 28(6 Pt 1):468-76. PubMed ID: 12522327
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
15. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Haffner SM; Agil A; Mykkanen L; Stern MP; Jialal I
Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
[TBL] [Abstract][Full Text] [Related]
16. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of the thickness of preperitoneal and subcutaneous fat layer in the abdomen estimated by ultrasonography for diagnosing abdominal obesity in each type of impaired glucose tolerance in man.
Soyama A; Nishikawa T; Ishizuka T; Ito H; Saito J; Yagi K; Saito Y
Endocr J; 2005 Apr; 52(2):229-36. PubMed ID: 15863953
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of new WHO diagnostic criteria for diabetes on the prevalence of abnormal glucose tolerance in a heterogeneous Nepali population--the implications of measuring glycated hemoglobin.
Baral N; Koner BC; Karki P; Ramaprasad C; Lamsal M; Koirala S
Singapore Med J; 2000 Jun; 41(6):264-7. PubMed ID: 11109341
[TBL] [Abstract][Full Text] [Related]
19. Glycosylated haemoglobin levels in patients referred for oral glucose tolerance tests.
John WG; Richardson RW
Diabet Med; 1986 Jan; 3(1):46-8. PubMed ID: 2951135
[TBL] [Abstract][Full Text] [Related]
20. An assessment of the new NIH diagnostic criteria for diabetes mellitus according to insulin response in a 75 g oral glucose tolerance test and levels of hemoglobin AIC.
Kanatsuka A; Osegawa M; Makino H; Kanzaki T; Hashimoto N; Kumagai A
Horm Metab Res; 1982 Dec; 14(12):626-30. PubMed ID: 6759357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
